-
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News
Saturday, January 21, 2023 - 3:52pm | 533Drug discovery company Mindset Pharma (OTCQB: MSSTF) has been greenlighted by the US Patent and Trademark Office (USPTO) on its application “Psilocin Derivatives As Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.” The application includes the company’s...
-
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
Tuesday, November 22, 2022 - 9:04am | 365Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness Corp., has entered into a joint venture agreement with Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience and more than 30.000 patients treated, specializing in multidisciplinary...
-
The Three Pillars of Effective Ketamine Mental Health Treatment
Tuesday, November 1, 2022 - 11:14am | 1208By Kevin Nicholson, CEO of Delic and Ketamine Wellness Centers Americans spent $225 billion on mental health treatments and services in 2019, but nearly half the people using antidepressants recorded a relapse in symptoms. During that time, ketamine has become an increasingly...
-
Zappy Zapolin Believes Psychedelic Research Has Come Of Age
Sunday, October 30, 2022 - 4:37pm | 349On this episode of Trade to Black, we’re talking about the psychedelics industry coming of age with Zappy Zapolin, on the eve of Wonderland in Miami early next month. Wonderland is the biggest dedicated psychedelics conference that brings together some of the leading...
-
Mental Health Provider Expands Psychedelic-Assisted Therapy For Chronic & Serious Medical Illnesses
Friday, October 28, 2022 - 2:28pm | 449Numinus Wellness Inc. (OTCQX: NUMIF) announced the launch of its new clinical program, ketamine for chronic and serious medical illness, to be first introduced at Utah, BC and Quebec clinics and then expanded to Numinus' remaining facilities. The company’s model includes...
-
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
Wednesday, October 26, 2022 - 5:54pm | 549Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing the safety and efficacy of a single intravenous infusion (IV) dose of proprietary R-...
-
Treating Postpartum Depression With Cannabis Or Psychedelics Like Ketamine And MDMA: Does It Work?
Friday, October 21, 2022 - 12:49pm | 1192This article was originally published on Psychedelic Spotlight and appears here with permission. Postpartum depression impacts thousands with no good treatment options. Some people are now treating postpartum depression with psychedelics Despite impacting 1 in 7 women (and 1 in 10 men) postpartum...
-
Elon Musk's 'Exploratory Journeys' And Charts Explaining Benefits Of Psychedelics Over Alcohol
Tuesday, October 11, 2022 - 7:28pm | 517Elon Musk has been forthcoming about psychedelic drugs and is not shy about discussing them and their benefits. He’s also been supportive of cannabis legalization. The billionaire shared a chart with a friend, which showed MDMA and psychedelic mushrooms are healthier than...
-
Ketamine Telehealth: Is It Safe? Is It Here To Stay?
Saturday, October 8, 2022 - 1:20pm | 827This article was originally published on Microdose and appears here with permission. Ketamine telehealth is a bit of an enigma — an off-label drug combined with at-home treatment, allowed because of originally temporary Public Health Emergency legislation put in place for...
-
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Wednesday, October 5, 2022 - 11:56am | 855Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S. The most recent news includes the incorporation of a Western ketamine infusion clinic into a renowned network of clinics providing psychedelic-assisted...
-
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
Friday, September 30, 2022 - 4:15pm | 1283Amended Autopsy Confirms Elijah McClain Died From Ketamine Injected By Paramedics Called By Cops Elijah McClain, a 23-year-old Black man with no arrest record, was forcibly detained by police in Aurora Colorado in August 2019 while walking home from a local supermarket following a 911 call that his...
-
PharmaTher Provides Business Highlights And Releases Audited Annual Financials
Thursday, September 29, 2022 - 4:17pm | 537PharmaTher Holdings Ltd. (OTCQB: PHRRF) has published its operational and audited financial results for fiscal year ended May 31, 2022. The company, which focuses on delivering ketamine for treating mental health disorders closed the annual period as follows: Cash...
-
Amended Autopsy Finds Elijah McClain Died From Ketamine Injected By Paramedics Called By Cops
Monday, September 26, 2022 - 9:06pm | 510Elijah McClain, a 23-year-old Black man, was forcibly detained by police in Aurora Colorado while walking home from a local supermarket following a 911 call that his behavior was ‘sketchy.’ McClain was a self-taught musician who worked as a massage therapist. What...
-
PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease
Saturday, September 17, 2022 - 6:09pm | 631PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, announced Friday that the Phase 1/2 clinical study of ketamine in the treatment of levodopa-induced dyskinesia in Parkinson’s disease was presented at the MDS International Congress of...
-
Wellbeing Digital Reports 4Q Finances, 'Three Key Pillars' Stay Strong
Friday, September 16, 2022 - 4:05pm | 349Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period showed: Total revenue of $872.731 (CA$1,160,547), representing a 2.5% increase compared to...